Global Biosimilar Lymphocyte Modulator Market Report 2020-2030: Market is Expected to Decline by 5.57% Between 2019 and 2020 but Recover by 2023
Share this article Share this article ResearchAndMarkets.com's offering. Biosimilar Lymphocyte Modulator Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar lymphocyte modulator market. Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis and Celltrion. The global lymphocyte modulator market is expected to decline from $1.29 billion in 2019 to $1.21 billion in 2020 at a compound annual growth rate (CAGR) of -5.57%...
Source: prnewswire.com